The present invention provides pyrrolidinone derivatives as Factor Xa inhibitors and pharmaceutical compositions comprising the same. The invention also relates to processes for the preparation of such compounds, and the use of such compounds in medicine, particularly in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.
本发明提供
吡咯烷酮衍
生物作为因子Xa
抑制剂,以及包含这些衍
生物的药物组合物。本发明还涉及制备这些化合物的方法,以及在医学中使用这些化合物,特别是在改善需要因子Xa
抑制剂的临床病况方面的使用。